Gabor Forgo

An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta‐analysis

W. Ageno, N. Kucher, H. Ddungu, 2021, Journal of thrombosis and haemostasis : JTH.

Prevalent use of high-intensity statin therapy and LDL-C target attainment among PAD patients undergoing angioplasty.

N. Kucher, T. Sebastian, S. Barco, 2022, VASA. Zeitschrift fur Gefasskrankheiten.

Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections

Benjamin A Lipsky, I. Uçkay, Felix W. A. Waibel, 2023, Antibiotics.

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

N. Kucher, G. Colucci, M. Schindewolf, 2022, The Lancet Haematology.

Venous thromboembolism and chronic venous disease among people who inject drugs: A systematic review and meta-analysis

N. Kucher, T. Sebastian, S. Barco, 2023, Thrombosis Update.